We are live on ! Find out more
TTPH

Tetraphase Pharmaceuticals, Inc.
TTPH

Delisted

TTPH was delisted on the 28th of July, 2020.

105 hedge funds and large institutions have $264M invested in Tetraphase Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 33 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more call options, than puts

Call options by funds: $2.32M | Put options by funds: $1.78M

24% more capital invested

Capital invested by funds: $212M → $264M (+$51.7M)

0% more funds holding

Funds holding: 105105 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

21% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 33

Holders
105
Holders Change
Holders Change %
0%
% of All Funds
2.75%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
22
Increased
26
Reduced
33
Closed
22
Calls
$2.32M
Puts
$1.78M
Net Calls
+$541K
Net Calls Change
+$1.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
76
Citigroup
New York
$142K +$125K +624 +726%
UBS AM
77
UBS AM
Illinois
$124K
BSW
78
Buckingham Strategic Wealth
Missouri
$119K +$119K +595 New
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
$84K -$2.27M -11,401 -96%
BG
80
BlackRock Group
United Kingdom
$80K -$59.5K -298 -43%
CG
81
Cutler Group
California
$77K +$76.8K +385 New
MCM
82
Manchester Capital Management
Vermont
$75K
BNP Paribas Financial Markets
83
BNP Paribas Financial Markets
France
$72K -$3.79K -19 -5%
Legal & General Group
84
Legal & General Group
United Kingdom
$68K
PAM
85
Panagora Asset Management
Massachusetts
$66K +$48.3K +242 +272%
Barclays
86
Barclays
United Kingdom
$63K -$136K -682 -68%
JIC
87
Joel Isaacson & Co
New York
$50K +$49.9K +250 New
TDC
88
Thompson Davis & Co
Virginia
$38K
BlackRock
89
BlackRock
New York
$33K +$17.6K +88 +113%
WA
90
WFG Advisors
Texas
$32K
LTFS
91
Ladenburg Thalmann Financial Services
Florida
$31K
LWCFA
92
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$28K
Teacher Retirement System of Texas
93
Teacher Retirement System of Texas
Texas
$27K -$8.38K -42 -24%
Canada Life
94
Canada Life
Manitoba, Canada
$19K
CLOS
95
Compagnie Lombard Odier SCmA
Switzerland
$10K +$9.98K +50 New
Victory Capital Management
96
Victory Capital Management
Texas
$6K +$200 +1 +4%
PNC Financial Services Group
97
PNC Financial Services Group
Pennsylvania
$5K +$4.99K +25 New
Zurich Cantonal Bank
98
Zurich Cantonal Bank
Switzerland
$3K
JP Morgan Chase
99
JP Morgan Chase
New York
$3K +$2K +10 New
TRCT
100
Tower Research Capital (TRC)
New York
$2K -$81.6K -409 -97%

TTPH Hedge Fund Activity: Q4 2015 in Review

105 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q4 2015, worth a combined $264M — up 24% from $212M a quarter earlier.

Fund positioning in TTPH was balanced in Q4 2015: 22 funds opened new positions, 22 closed out, 26 added to existing stakes and 33 trimmed.

The largest buyer was Canada Pension Plan Investment Board, opening a new position worth an estimated $19.7M. The largest seller was State Street, cutting an estimated $22.9M.

  • 105 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $264M of Tetraphase Pharmaceuticals, Inc. stock for Q4 2015, up 24% quarter-over-quarter.
  • 22 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q4 2015 and 22 closed out, a net change of 0 holders.
  • The largest Tetraphase Pharmaceuticals, Inc. buyer in Q4 2015 was Canada Pension Plan Investment Board, an estimated $19.7M added.
  • The largest Tetraphase Pharmaceuticals, Inc. seller in Q4 2015 was State Street, an estimated $22.9M sold.

Based on aggregated 13F filings for Q4 2015.